Clinical Trial Financial Management Technology 101 Workshop: Leveraging Technology to Lower your Site Burden ($, TECH)
Technology is changing the way clinical trials are being conducted. In this session, you will learn the core Clinical Trial Financial Management technologies that are powering clinical trials today and how they are improving the site experience. In addition, we will talk through some of the more advanced technologies that are becoming mainstream and how you can engage with your CROs and/or Sponsors to ensure they are leveraging these technologies.
Jeffrey Kearney, VP, Product Management Payments, Medidata Solutions, a Dassault Systèmes company
Tom Creswell, Director Product Management, Medidata Solutions, a Dassault Systèmes company
Shelley Doruos, Director of Product, Clinical Trial Planning & Budgeting, Medidata, a Dassault Systèmes company
Looking to be Acquired and What to Expect
This will be an open discussion about site acquisitions. We will share several critical issues that you need to be aware of as you undertake this process. This will include discussion of essential information for evaluation. There will be discussion of basic systems that will be expected to optimize your value.
William B. Smith, MD, CEO, Alliance for Multispeciality Research
Neil McCarthy, Managing Director, Fairmont Partners Investment Banking
Sean Karamchandani, Partner, Presistance Capital Partners
Kumar Muthalagappan, CEO, Chairman, Oncacare
*Sites Only Session
No going back, preparing sites for trials of the future
